AURA Insider Transactions
79 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–79; provenance stays internal.
AURA insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Gibney Anthony S | See Remarks | 2026-06-16 | Sale | 12,824.0 | $6.42 |
| Matrix Capital Management Company, LP | TenPercentOwner | 2026-05-07 | Sale | 6,922,870.0 | $5.64 |
| GOEL DAVID E. | TenPercentOwner | 2026-05-07 | Sale | 6,922,870.0 | $5.64 |
| Kilroy Conor | See Remarks | 2026-04-16 | Sale | 11,738.0 | $7.02 |
| Kilroy Conor | See Remarks | 2026-02-17 | Sale | 12,079.0 | $5.05 |
| Plavsic Mark | Chief Technology Officer | 2026-02-17 | Sale | 15,890.0 | $5.05 |
| Hopkins Janet Jill | Chief Medical Officer | 2026-02-17 | Sale | 20,401.0 | $5.06 |
| Elazzouzi Amy | Senior Vice President, Finance | 2026-02-17 | Sale | 8,549.0 | $5.06 |
| de los Pinos Elisabet | See Remarks | 2026-02-17 | Sale | 47,648.0 | $5.06 |
| Elazzouzi Amy | Senior Vice President, Finance | 2026-01-20 | Sale | 1,581.0 | $4.86 |
| de los Pinos Elisabet | See Remarks | 2026-01-20 | Sale | 16,928.0 | $4.86 |
| Hopkins Janet Jill | Chief Medical Officer | 2025-11-17 | Sale | 17,109.0 | $5.42 |
| Elazzouzi Amy | Senior Vice President, Finance | 2025-10-29 | Sale | 896.0 | $6.35 |
| de los Pinos Elisabet | See Remarks | 2025-10-29 | Sale | 9,049.0 | $6.35 |
| Plavsic Mark | Chief Technology Officer | 2025-10-16 | Sale | 12,169.0 | $6.35 |
| Elazzouzi Amy | Senior Vice President, Finance | 2025-08-18 | Sale | 7,722.0 | $6.7 |
| Johnson David Michael | Director | 2025-05-16 | Purchase | 20,000.0 | $4.9 |
| Gibney Anthony S | See Remarks | 2025-05-16 | Sale | 1,519.0 | $5.15 |
| Gibney Anthony S | See Remarks | 2025-05-16 | Purchase | 50,000.0 | $4.9 |
| Elazzouzi Amy | Senior Vice President, Finance | 2025-04-16 | Sale | 897.0 | $5.49 |
| Kilroy Conor | See Remarks | 2025-04-16 | Sale | 7,162.0 | $5.49 |
| Plavsic Mark | Chief Technology Officer | 2025-02-18 | Sale | 2,151.0 | $7.75 |
| Elazzouzi Amy | Senior Vice President, Finance | 2025-02-18 | Sale | 1,404.0 | $7.75 |
| Hopkins Janet Jill | Chief Medical Officer | 2025-02-18 | Sale | 2,534.0 | $7.75 |
| de los Pinos Elisabet | See Remarks | 2025-02-18 | Sale | 20,221.0 | $7.75 |
| de los Pinos Elisabet | See Remarks | 2025-01-21 | Sale | 15,955.0 | $7.67 |
| Elazzouzi Amy | Vice President, Finance | 2025-01-21 | Sale | 1,001.0 | $7.67 |
| Hopkins Janet Jill | Chief Medical Officer | 2024-11-18 | Sale | 11,822.0 | $9.36 |
| de los Pinos Elisabet | See Remarks | 2024-10-29 | Sale | 9,200.0 | $10.74 |
| Elazzouzi Amy | Vice President, Finance | 2024-10-29 | Sale | 553.0 | $10.74 |
| Feder Julie B | Chief Financial Officer | 2024-10-18 | Sale | 25,131.0 | $12.03 |
| de los Pinos Elisabet | See Remarks | 2024-10-18 | Sale | 24,992.0 | $12.04 |
| Plavsic Mark | Chief Technology Officer | 2024-10-16 | Sale | 7,383.0 | $9.85 |
| de los Pinos Elisabet | See Remarks | 2024-01-23 | Sale | 15,853.0 | $7.64 |
| Feder Julie B | Chief Financial Officer | 2024-01-23 | Sale | 6,609.0 | $7.64 |
| Matrix Capital Management Company, LP | TenPercentOwner | 2023-11-09 | Purchase | 1,560,000.0 | $9.0 |
| GOEL DAVID E. | TenPercentOwner | 2023-11-09 | Purchase | 1,560,000.0 | $9.0 |
| Johnson David Michael | Director | 2023-11-08 | Purchase | 10,000.0 | $7.3 |
| Johnson David Michael | Director | 2023-11-08 | Purchase | 10,000.0 | $7.3 |
| Johnson David Michael | Director | 2023-11-08 | Purchase | 9,601.0 | $7.3 |
| Johnson David Michael | Director | 2023-11-07 | Purchase | 47,000.0 | $7.17 |
| Johnson David Michael | Director | 2023-11-07 | Purchase | 47,000.0 | $7.17 |
| Johnson David Michael | Director | 2023-11-07 | Purchase | 76,000.0 | $7.17 |
| de los Pinos Elisabet | See Remarks | 2023-11-06 | Sale | 7,449.0 | $12.03 |
| Feder Julie B | Chief Financial Officer | 2023-11-06 | Sale | 3,900.0 | $12.07 |
| Feder Julie B | Chief Financial Officer | 2023-10-30 | Sale | 3,385.0 | $6.82 |
| de los Pinos Elisabet | See Remarks | 2023-10-30 | Sale | 9,586.0 | $6.83 |
| Johnson David Michael | Director | 2023-10-04 | Purchase | 6,566.0 | $8.61 |
| Johnson David Michael | Director | 2023-10-03 | Purchase | 13,500.0 | $8.27 |
| Johnson David Michael | Director | 2023-01-06 | Purchase | 904.0 | $10.51 |
| Johnson David Michael | Director | 2023-01-06 | Purchase | 700.0 | $10.5 |
| Johnson David Michael | Director | 2023-01-05 | Purchase | 96.0 | $10.0 |
| Johnson David Michael | Director | 2023-01-05 | Purchase | 300.0 | $10.0 |
| Johnson David Michael | Director | 2022-12-28 | Purchase | 2,000.0 | $9.75 |
| Johnson David Michael | Director | 2022-12-28 | Purchase | 2,000.0 | $9.75 |
| Matrix Capital Management Company, LP | TenPercentOwner | 2022-12-05 | Purchase | 1,250,000.0 | $12.0 |
| GOEL DAVID E. | TenPercentOwner | 2022-12-05 | Purchase | 1,250,000.0 | $12.0 |
| Johnson David Michael | Director | 2022-12-01 | Purchase | 5,000.0 | $12.37 |
| Johnson David Michael | Director | 2022-12-01 | Purchase | 5,000.0 | $12.37 |
| Feder Julie B | Chief Financial Officer | 2022-10-31 | Sale | 2,015.0 | $12.45 |
| Rich Cadmus | See Remarks | 2022-10-31 | Sale | 1,672.0 | $12.45 |
| de los Pinos Elisabet | See Remarks | 2022-10-31 | Sale | 5,706.0 | $12.46 |
| De Rosch Mark | Chief Operating Officer | 2022-10-31 | Sale | 1,115.0 | $12.46 |
| Johnson David Michael | Director | 2022-06-13 | Purchase | 20,000.0 | $13.99 |
| Johnson David Michael | Director | 2022-06-13 | Purchase | 7,000.0 | $13.99 |
| Johnson David Michael | Director | 2022-06-13 | Purchase | 7,000.0 | $13.99 |
| Johnson David Michael | Director | 2022-06-10 | Purchase | 10,000.0 | $15.04 |
| Johnson David Michael | Director | 2022-06-10 | Purchase | 3,000.0 | $15.04 |
| Johnson David Michael | Director | 2022-06-10 | Purchase | 3,000.0 | $15.04 |
| Matrix Capital Management Company, LP | TenPercentOwner | 2021-11-02 | Purchase | 1,785,000.0 | $14.0 |
| GOEL DAVID E. | TenPercentOwner | 2021-11-02 | Purchase | 1,785,000.0 | $14.0 |
| Medicxi Growth I LP | TenPercentOwner | 2021-11-02 | Purchase | 16,475.0 | $14.0 |
| Medicxi Growth Co-Invest I LP | TenPercentOwner | 2021-11-02 | Purchase | 16,475.0 | $14.0 |
| Medicxi Ventures Management (Jersey) Ltd | TenPercentOwner | 2021-11-02 | Purchase | 16,475.0 | $14.0 |
| Medicxi Growth I GP Ltd | TenPercentOwner | 2021-11-02 | Purchase | 16,475.0 | $14.0 |
| Medicxi Growth I LP | TenPercentOwner | 2021-11-02 | Purchase | 693,525.0 | $14.0 |
| Medicxi Growth Co-Invest I LP | TenPercentOwner | 2021-11-02 | Purchase | 693,525.0 | $14.0 |
| Medicxi Ventures Management (Jersey) Ltd | TenPercentOwner | 2021-11-02 | Purchase | 693,525.0 | $14.0 |
| Medicxi Growth I GP Ltd | TenPercentOwner | 2021-11-02 | Purchase | 693,525.0 | $14.0 |